Molecular mechanisms underlying apoptosis in retinitis pigmentosa, as in other neurodegenerative diseases, are still elusive, and this fact hampers the development of a cure for this blinding disease. We show that two apoptotic pathways, one from the mitochondrion and one from the endoplasmic reticulum, are coactivated during the degenerative process in an animal model of retinitis pigmentosa, the rd1 mouse. We found that both AIF and caspase-12 translocate to the nucleus of dying photoreceptors in vivo and in an in vitro cellular model. Translocation of both apoptotic factors depends on changes in intracellular calcium homeostasis and on calpain activity. Knockdown experiments defined that AIF plays the major role in this apoptotic event, whereas caspase-12 has a reinforcing effect. This study provides a link between two executor caspase-independent apoptotic pathways involving mitochondrion and endoplasmic reticulum in a degenerating neuron.
Molecular mechanisms underlying apoptosis in retinitis pigmentosa, as in other neurodegenerative diseases, are still elusive, and this fact hampers the development of a cure for this blinding disease. We show that two apoptotic pathways, one from the mitochondrion and one from the endoplasmic reticulum, are coactivated during the degenerative process in an animal model of retinitis pigmentosa, the rd1 mouse. We found that both AIF and caspase-12 translocate to the nucleus of dying photoreceptors in vivo and in an in vitro cellular model. Translocation of both apoptotic factors depends on changes in intracellular calcium homeostasis and on calpain activity. Knockdown experiments defined that AIF plays the major role in this apoptotic event, whereas caspase-12 has a reinforcing effect. This study provides a link between two executor caspase-independent apoptotic pathways involving mitochondrion and endoplasmic reticulum in a degenerating neuron.
rd1 mouse ͉ photoreceptor ͉ retinal stem cells R etinitis pigmentosa (RP) is a form of retinal degeneration resulting from rod photoreceptor cell death and leading to blindness. Despite the remarkable genetic heterogeneity of this disease, photoreceptors undergo a common mode of cell death: apoptosis. An autosomal recessive form of RP is caused by mutations in the rod-specific ␤-catalytic subunit of the phosphodiesterase gene PDE6B (1) . The naturally occurring retinal degeneration (rd1) mouse is the animal model for this type of RP (2) . The rd1 mouse has elevated levels of cGMP (3, 4) , and this elevation results in elevated intracellular calcium (5) . Ca 2ϩ concentration within the cytosol as well as Ca 2ϩ tides and ebbs within various organelles, such as mitochondria, nucleus, and endoplasmic reticulum (ER), are important in regulating many cellular functions such as neuronal survival or cell death.
There are instances, most notably after Ca 2ϩ overload, in which the cell-death pathway elicited differs from classical caspasemediated apoptosis. Calpains are cysteine proteases activated by calcium during apoptotic processes (6) . Calpain I and II (-and m-calpain) are expressed in the retina (7) , and recent reports showed activation of calpain and cathepsin D in rd1 mice (5, 8) . Several proteins are known targets of calpain protease activity, such as caspase-12 and apoptosis-inducing factor (AIF). Caspase-12, localized to the ER (9), can be activated by m-calpain in the presence of the pancaspase inhibitor zVAD.fmk (10) . Interestingly, caspase-12 has been linked to neuronal degeneration in neurotoxicity caused by amyloid-␤ protein (9) , by prion protein (11) , and in animal models of ALS (12) . The cleaved active form of caspase-12 participates to the apoptotic event by translocation to the nucleus (13); however, it is unclear whether caspase-12 can induce chromatin fragmentation. AIF also directly translocates to the nucleus to execute DNA fragmentation that culminates in cell death (14) . The translocation of AIF from mitochondria to the nucleus has been implicated in neuronal demise and in photoreceptor cell death after retinal detachment (15) (16) (17) . Cleavage and release of AIF from mitochondria is regulated by -calpain (18) and can occur independently from cytochrome c release (19) .
In this study, we demonstrate a direct correlation of increased intracellular Ca 2ϩ , calpain activation, and nuclear translocation of AIF and caspase-12 in apoptotic photoreceptors. We also show that AIF plays the key role in apoptosis activation. Finally, we provide evidences that treatment with calpain inhibitors is able to block activation of AIF and caspase-12 and, consequently, apoptosis in vitro and in vivo.
Results

AIF and Caspase-12
Are Activated During Apoptosis in rd1 Retinas. To investigate which apoptotic pathway is activated during the degenerative process in rd1 retinas, we analyzed changes in subcellular localization of two factors involved in intrinsic apoptotic signals, AIF and caspase-12. Based on our analysis of apoptosis progression and on other reports (20), we chose P11 for all our studies. At this stage, rods are undergoing apoptosis, followed then by cones not expressing Pde6b (21) . AIF is a mitochondrial protein mostly localized in the inner segment of photoreceptor cells containing mitochondria and ER and in the cytoplasm of other retinal cells ( Fig. 1A ; and see Fig. 6A , which is published as supporting information on the PNAS web site). In rd1 retinas, AIF could be detected in some photoreceptor nuclei and colocalized with TUNEL that labels chromatin fragmentation in cells undergoing apoptosis (Figs. 1 E-H and 6B) . Similarly, in wild-type (wt) mice, caspase-12 is preferentially found in the inner segment containing the ER of photoreceptor cells (Figs. 1B and 6C ). Double labeling with TUNEL showed caspase-12 in the nucleus of rd1 cells undergoing apoptosis (Figs. 1 F-H and 6D ). Interestingly, we found that all nuclei containing activated AIF also contained activated caspase-12. We calculated that 80% of the cells in apoptosis also showed nuclear staining for AIF and caspase-12 (Fig. 1M ). This same analysis was performed also at postnatal day (P)10 and P13, and we calculated similar percentages of AIF-and caspase-12-positive nuclei (data not shown), suggesting that lack of detection of AIF and caspase-12 in 20% of apoptotic photoreceptors is not because of the time chosen for our analysis. Western blot analysis confirmed nuclear localization of AIF and activated caspase-12 fragments in rd1 and not in the wt retinas (Fig. 1N) . No activated caspase-3 or caspase-9 were detectable in cytosol extracts from wt and rd1 retinas (data not shown), as expected from other reports (22, 23) . Translocation of AIF and caspase-12 appeared specific; in fact, no changes in subcellular localizations of mitochondrial cytochrome c and ER marker ERAB were observed in rd1 photoreceptors ( Fig. 6 E-H) .
Finally, we treated wt mice with nitrosomethyl-urea, causing massive and fast apoptosis in the retina. In these conditions, almost all photoreceptor nuclei were TUNEL-positive, but none of them showed nuclear localization of either AIF or caspase-12 ( Fig. 1  I-L) , demonstrating that their translocation was specific to the genetic pathological condition.
In Vitro Analysis of AIF and Caspase-12 Activation in rd1 Photoreceptors. To better characterize, at a molecular level, colocalization of AIF and caspase-12 and the cells undergoing apoptosis, we took advantage of an in vitro system to differentiate photoreceptor cells. Neurospheres, derived from the adult ciliary margin were in vitro-differentiated to the various retinal neuronal cell types (24) . Photoreceptors were characterized by expression of three different markers (rhodopsin, Pde6␤, and cGMP-gated channel Cnga). Approximately 40% of the wt cells in culture expressed the three photoreceptor-specific proteins, whereas cells derived from rd1 mice expressed rhodopsin and Cnga, but not Pde6␤, as expected ( Fig. 2 A-E, G, H, J, and K). Interestingly, we found that only rd1-differentiated cells were undergoing apoptosis in vitro ( Fig. 2 F,  I , and L). All apoptotic cells were also expressing photoreceptor markers, and apoptosis was never observed in cells labeled with markers for amacrine and bipolar and horizontal retinal neurons ( Fig. 2 
M-O).
Subcellular localizations of AIF and caspase-12 were analyzed in wt and rd1 photoreceptors in vitro. In these experiments, cells were treated with retinoic acid to achieve a faster and higher rod differentiation. Both AIF and caspase-12 localized inside the apoptotic nuclei of rd1 cells (Fig. 3 E-H, arrows) differently from wt cells (Fig. 3 A-D) . As shown in vivo, also in in vitro-differentiated photoreceptors AIF and caspase-12 colocalized in the apoptotic nuclei (Fig. 3H, arrows) . We also analyzed cytochrome c localization, and we did not detect mitochondrial release of cytochrome c during photoreceptor apoptosis ( Fig. 3 I and J) . This finding confirmed the specificity of translocation of AIF not affecting other mitochondrial molecules, and this was true also for caspase-12 as analyzed with an ER-localized protein (ERAB) ( Fig. 3 K and L) . Finally, to define whether activation of AIF and caspase-12 was correlated to changes in intracellular Ca 2ϩ concentration, we compared Ca 2ϩ content between wt and rd1 in in vitrodifferentiated photoreceptors. A progressive increase in Ca 2ϩ concentration was detected in rd1 cells during differentiation ( Fig. 3 
We measured the enhancement in intracellular Ca 2ϩ levels in rd1 cells of three times after 11 days in culture, and treatment with cis-diltiazem, a calcium blocker, prevented calcium increase (Fig.  3O) . Finally, by treatment of wt in vitro-differentiated photoreceptors with thapsigargin, which inhibits ER-associated Ca 2ϩ -ATPase and disrupts Ca 2ϩ homeostasis (25), we observed cotranslocation of AIF and caspase-12 inside apoptotic nuclei (Fig. 7 , which is published as supporting information on the PNAS web site). These data confirmed a direct correlation of intracellular Ca 2ϩ concentration and translocation of apoptotic factors inside the nuclei.
We tracked the sequence of events during photoreceptor apoptosis. We found that, at 10 days of culture, the percentage of cells with high Ca 2ϩ ( Fig. 3 N and Q) is similar to cells activating calpain ( Fig. 3 P and Q) and higher than TUNEL ϩ , nuclear AIF ϩ , and caspase-12 ϩ cells. We also detected cells in which calpains were activated but chromatin was not yet fragmented (Fig. 3P) . At 9 and 10 days of differentiating culture, we observed a low percentage of cells in which AIF and caspase-12 have a nuclear localization but that are not yet labeled with TUNEL. Up-regulation of Caspase-12 mRNA in rd1 cells was also detected (Fig. 3R) , as reported in motor-neuron degeneration (12) .
All together, our data show that increase of intracellular Ca 2ϩ in differentiated rods is directly correlated to calpain activation and, subsequently, to translocation of AIF and caspase-12 to nuclei. Furthermore, lack of cytochrome c release from mitochondria confirmed that translocations of AIF and caspase-12 are independent of executor caspase activation.
Roles of AIF and Caspase-12 During the Degenerative Process. To address the interaction between AIF and caspase-12 in degenerating photoreceptors, we used RNAi to knock down either AIF or caspase-12 in in vitro-differentiated rd1 photoreceptors. Short hairpin (sh)RNAs showed high efficiency to knock down AIF (Fig. 4 A,  D, and O) and caspase-12 (Fig. 4 H, K, and P) . To rule out nonspecific effects of shRNAs, we designed a second shRNA for each gene and confirmed that off-target effects are not responsible for the observed phenotype. Furthermore, down-regulation of AIF did not affect subcellular localization of mitochondrial cytochrome c, and down-regulation of caspase-12 did not affect ER marker ERAB (Fig. 8 , which is published as supporting information on the PNAS web site). Mutagenized shRNAs were used as controls (Fig.  4 A-C and G-I) . When AIF was down-regulated, a reduced number of photoreceptors showed caspase-12 translocation to the nucleus (Fig. 4 E, arrows, and M) , and no chromatin fragmentation could be detected by TUNEL staining (Fig. 4 F and M) . Conversely, down-regulation of caspase-12 only slightly reduced the percentage of dying cells (30% reduction, Fig. 4N) , and all cells undergoing apoptosis showed nuclear localization of AIF, suggesting a primary role of AIF in this apoptotic event (Fig. 4 J-N) . AIF is therefore necessary to activate apoptosis, whereas translocation of caspase-12 is not sufficient to induce apoptosis in photoreceptor cells. Similar results were obtained with the second shRNAs targeting either AIF or caspase-12 (Fig. 8) .
Knockdown experiments suggested that mitochondrial and ER pathways are activated independently; however, the two pathways interact by reinforcing each other, as indicated by the reduced number of photoreceptors with nuclear localization of caspase-12 in AIF Ϫ cells or AIF in casp-12 Ϫ cells.
Calcium Channel Blocker Interferes with AIF and Caspase-12 Activation. To confirm that changes in Ca 2ϩ homeostasis cause AIF and caspase-12 relocalization, we treated rd1 pups with the calcium channel blocker cis-diltiazem, a drug reported to be able to slow retinal degeneration in rd1 mice (26) . A significant decrease of apoptotic nuclei was found at P11. However, TUNEL-positive cells were still detectable, and histological analysis of cis-diltiazemtreated rd1 retinas defined advanced degeneration at P21 (Fig. 5I and data not shown). No nuclear translocation of either AIF or caspase-12 was detectable by triple staining of cis-diltiazem-treated rd1 retinas (Fig. 5 A-D) . We also detected a strong decrease of activated AIF and caspase-12 fragments in the nuclear fraction of retinas treated with the calcium blocker (Fig. 5K) . cis-diltiazem was also able to reduce apoptosis in vitro (Fig. 5J) and prevented AIF and caspase-12 translocation to the nucleus (data not shown). These data implied that changes in Ca 2ϩ concentration are strictly linked to activation of multiple apoptotic pathways in rd1 retinas.
Calpain Inhibitors Interfere with AIF and Caspase-12 Activation and
Block Apoptosis in the rd1 Retina. Cleavage and release of AIF from the mitochondria is mediated by calpain I (18), whereas caspase-12 is processed by calpain II (10) . Based on this evidence, we reasoned that by blocking both calpain activities, we might prevent AIF and caspase-12 activation and, consequently, apoptosis. We intravitreously injected rd1 eyes with either calpain inhibitors I (ALLN) or II (ALLM) or a mixture of both. We injected calpain inhibitors at concentrations reported for the eye (7). After treatment with both calpain inhibitors, we were unable to detect apoptotic cells in the rd1 retina or in in vitro-differentiated photoreceptors (Fig. 5 G-I) . In vivo treatments with ALLM or ALLN were not as effective as with the two inhibitors together (Fig. 5I) . We never detected AIF and caspase-12 inside photoreceptor nuclei treated with ALLN and ALLM (Fig. 5 E-H) . Western blot analysis confirmed that treatment with ALLN and ALLM was inhibiting AIF and caspase-12 activation (Fig. 5K) . On the contrary, in vivo and in vitro treatment of rd1 photoreceptors with pancaspase inhibitor zVAD.fmk had only a minor effect in preventing apoptosis and did not prevent nuclear localization of AIF and caspase-12 ( Fig. 5 I and J and L  and M) .
Discussion
During the last 20 years, the molecular causes of RP were unraveled, and apoptosis was identified as the common mechanism causing photoreceptor demise in this genetically heterogeneous disease. Nevertheless, important questions on programmed cell death remained unsolved, and little is known about the apoptotic molecules activated in retinal degeneration. Here, we molecularly characterized apoptosis in photoreceptors with Pde6b gene inactivation. We report concomitant translocation to the nucleus of a mitochondrial protein, AIF, and of a caspase normally localized to the ER. We observed that cotranslocation of AIF and caspase-12 in apoptotic photoreceptor nuclei follows increase of intracellular Ca 2ϩ and calpain activation. The strict correlation with changes in Ca 2ϩ homeostasis was confirmed by treatment with the calciumchannel blocker cis-diltiazem, which was able to reduce intracellular Ca 2ϩ , interfere with translocation to the nucleus of both factors, and reduce apoptosis. We still cannot explain why the drug was unable to abolish apoptosis in vivo. The efficacy of cis-diltiazem in protecting against photoreceptor apoptosis is still controversial. Some studies provided evidence of photoreceptor rescue (26) . In contrast, other studies did not detect beneficial effects in this same model (27) or in a canine model (28) . By calculating the number of apoptotic cells during cis-diltiazem treatment, we detected some beneficial effect at early stages during the degenerative process; however, this drug was unable to completely block apoptosis, and the retina eventually underwent complete degeneration. We think that the in vivo treatment of mice with cis-diltiazem does not allow all photoreceptors to be exposed to the proper concentration, whereas the in vitro studies allow a more homogeneous exposure to the drug. Secondly, cis-diltiazem blocks all calcium channels and therefore deeply changes photoreceptor metabolism and interactions with adjacent cells, and this change may hamper the positive effects of the drug.
More interestingly, RNAi experiments implied that the two apoptotic factors are independently activated but partially affect each other. In fact, translocation to the nucleus of either AIF or caspase-12 can still be detected in the absence of the other factor, but in a low percentage of cells. We also demonstrated that AIF plays a crucial role in the apoptotic event of photoreceptor cells, whereas caspase-12 has a marginal role. In fact, down-regulation of this protein only partially rescues cells from apoptosis. Unfortunately, in vivo down-regulation of AIF cannot be tested because it causes degeneration of cerebellar and retinal neurons in the Harlequin mouse (29) . It is therefore important to develop a system able to prevent AIF translocation to the nucleus without impairing its important physiological functions in the mitochondria. Our in vivo positive results with calpain-inhibitor treatments are the first attempt toward this aim and demonstrate the effectiveness of these drugs in blocking AIF activation. Our results are in line with the study showing a beneficial effect of different calpain inhibitors in retinal explant cultures (8) , whereas it is not in agreement with a report showing no effect on photoreceptor degeneration by treatment with the calpain inhibitor ALLN (5). This discrepancy may be due to differences in the technical approaches used: Doonan et al. used retinal explants, whereas we treated mice in vivo; second, we used a mixture of two calpain inhibitors with high concentrations that are not toxic for the retina in vivo.
How can we explain the 20% of photoreceptors in which we did not observe AIF and caspase-12 translocation to the nucleus? We cannot exclude that our in situ detection of AIF and caspase-12 fails to detect low amounts of these factors in some apoptotic nuclei. In fact, photoreceptors in an advanced apoptotic status may degrade intracellular proteins like AIF and caspase-12, whereas the nucleus can still be labeled by TUNEL. We can also postulate that a third apoptotic pathway is activated in different photoreceptors, either independently or as a consequence of cell death in the surrounding cells. The minor effect of pancaspase inhibitor in reducing apoptosis in vivo and in vitro but not in preventing AIF and caspase-12 nuclear translocation may support this hypothesis; however, it may also imply a partial, but not key, function of effector caspases, as suggested (23) .
In conclusion, the option of exploiting apoptosis as a therapeutic target is complex. Nevertheless, the molecular understanding of the different apoptotic factors activated during degeneration and the 
